SAN DIEGO--(BUSINESS WIRE)--Sept. 20, 2006--Aethlon Medical, Inc., (OTCBB:AEMD) a pioneer in developing therapeutic devices for infectious disease, announced today that its President, Hal Handley, Ph.D. will present at The United States Conference on AIDS (USCA) this Friday, the 22nd of September. As a follow-up to Aethlon’s presentation at the XVI International AIDS Conference, Dr. Handley will review targeted applications of the Aethlon Hemopurifier(TM), including its potential to combat drug-resistant HIV during “The Biotech Research Forum,” a showcase of innovative advances in the treatment of HIV/AIDS.
